Stocks Comparison
Incyte vs Maxcyte: revenue, profit, margins and growth compared
Incyte brought in $5.1B of revenue in fiscal 2025, Maxcyte $33M in fiscal 2025. Revenue changed by +21.2% at Incyte and -14.5% at Maxcyte on the year before, so Incyte grew faster. Incyte kept 25.0% of its revenue as net profit, Maxcyte -135.1%.
Side by side, latest fiscal year
| INCY | MXCT | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $5.1B | $33M |
| Revenue growth | +21.2% | -14.5% |
| Net income | $1.3B | -$44.6M |
| Net margin | 25.0% | -135.1% |
| Free cash flow | n/a | -$36.2M |
| Free cash flow margin | n/a | -109.5% |
| Earnings per share (diluted) | $6.41 | -$0.42 |
| Cash | $3.1B | $20.1M |
| Debt | n/a | n/a |
| Price to earnings | 19.3 | n/a |
| Market value | $25.1B | $120.8M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #60 of 523 · Health care | #390 of 523 · Health care |
Over the years
INCY $5.1BMXCT $33M
INCY $1.3BMXCT -$44.6M
INCY 25.0%MXCT -135.1%
INCY +21.2%MXCT -14.5%
INCY $892.1MMXCT -$36.2M
Questions about Incyte and Maxcyte
Which is bigger by revenue, Incyte or Maxcyte?
Incyte is bigger by revenue: $5.1B in fiscal 2025, against $33M for Maxcyte in fiscal 2025.
Which keeps more of its revenue as profit, Incyte or Maxcyte?
Incyte had a net margin of 25.0% in fiscal 2025; Maxcyte had -135.1% in fiscal 2025.
Which grew revenue faster, Incyte or Maxcyte?
In their latest fiscal years revenue changed by +21.2% at Incyte and -14.5% at Maxcyte.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.